We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Astellas Pharma Inc (PK) | USOTC:ALPMY | OTCMarkets | Depository Receipt |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
10.73 | 10.76 | 11.03 | 10.705 | 11.03 |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
15:00:02 | 2 | 10.76 | USD |
Date | Time | Source | Headline |
---|---|---|---|
15/12/2023 | 22:53 | DJN | Merck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus Padcev |
30/11/2023 | 23:04 | DJN | Astellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License.. |
22/9/2023 | 11:02 | DJN | Merck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits Endpoints |
07/8/2023 | 14:41 | DJN | Poseida Therapeutics Shares Leap on Astellas Investments |
07/8/2023 | 13:58 | DJN | Poseida Therapeutics in $50 Million Investment Deal With Astellas |
01/5/2023 | 00:57 | DJN | Astellas Pharma to Buy Iveric Bio for About $5.9 Billion |
Astellas Pharma (PK) (ALPMY) Charts1 Year Astellas Pharma (PK) Chart |
|
1 Month Astellas Pharma (PK) Chart |
Intraday Astellas Pharma (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions